Ondine Biomedical Inc., a life-sciences company, engages in the development and commercialization of treat infections, and drug-resistant pathogens antimicrobial therapies in Canada and internationally. The company’s main product like Steriwave. It threats protect patients, and preserve the effectiveness of antibiotics. In addition, the company products pipeline platform includes burns, ventilator tube, and sinus; and serious, chronic wounds, chronic sinusitis, ventilator-associated pneumonia VAP, central line bloodstream infections CLABSI, as well as catheter-associated urinary tract infection CAUTI. The company was incorporated in 1996 and is headquartered in Vancouver, Canada.